A detailed history of Jones Financial Companies Lllp transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Jones Financial Companies Lllp holds 1,615 shares of AUPH stock, worth $13,388. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,615
Holding current value
$13,388
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 05, 2025

BUY
$6.75 - $10.44 $10,901 - $16,860
1,615 New
1,615 $14,000
Q2 2024

Aug 14, 2024

BUY
$4.81 - $5.78 $3,366 - $4,046
700 New
700 $3,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.18B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Jones Financial Companies Lllp Portfolio

Follow Jones Financial Companies Lllp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jones Financial Companies Lllp, based on Form 13F filings with the SEC.

News

Stay updated on Jones Financial Companies Lllp with notifications on news.